Inpefa

I was part of the development team that built the rebranded site for Inpefatogether.com during my time at The Bloc in 2024. Inpefa (sotagliflozin) is a medication used to treat heart failure. It works by inhibiting sodium-glucose cotransporters (SGLT1 and SGLT2), helping improve heart and kidney function. It reduces the risk of cardiovascular death and hospitalizations due to heart failure, benefiting both diabetic and non-diabetic patients. It has been shown to improve outcomes for individuals with heart failure, regardless of ejection fraction